Химия и фармацевтические продукты

In August 2008, Ukraine’s imports of pharmaceutical increased by 34.% YoY. In value terms, it increased by USD 50.618 mln to reach USD 197.364 mln.

After a number of hostile takeover attempts in recent years, the Borshahivskiy Chemical Pharmaceutical Plant (BCPP) is planning to sell its factory. BCPP is the number one Ukrainian producer in terms of GMP compliance.

The CJSC “Borshchagivskiy Chemical Pharmaceutical Plant” has announced its intention to sell up to 69% of its common shares on October 28, 2008. The estimated price per share in this sellout deal will be equal to USD 20,191.28 in its UAH equivalent.

Concern Stirol [STIR UZ, U/R] stated in a press release that the last of its three ammonia synthesis aggregates has been modernized.

The President of the Ukrainian Pharmaceutical Association, Petro Bagriy,announced that leading pharmaceutical companies in Ukraine are ready to cut their prices.

Prime Minister Yuliya Tymoshenko has underlined the unsatisfying quality of pharmaceuticals considering their high prices.

According to various news sources, which cited the press service of Concern Stirol [STIR UZ, U/R], the company redeemed USD 125 mln of Eurobonds.

According to Interfax-Ukraine, shareholders of Kyivmedpreparat [KMED UZ, U/R] will vote on a share capital increase at a September 30 EGM. The current plan calls for placing (with existing shareholders only) 4 mln new shares at a face value of UAH 25 (USD 5.43 at USD/UAH 4.6020) during the period December 09-25.

Concern Stirol [STIR UZ, U/R] reported its operational results and sales data on July 10.

Concern Stirol [STIR UZ, U/R] was the first company to pre-register some substances for REACH.